Device longevity prediction for a device having variable energy consumption

• US 9,126,054 B2
• Filed: 05/13/2014
• Issued: 09/08/2015
• Est. Priority Date: 04/14/2011
• Status: Active Grant

• Current Assignee: LivaNova USA, Inc. (LivaNova Plc)
• Original Assignee: Cyberonics, Inc
• Inventors: Colborn, John C.
• Primary Examiner(s): Gedeon, Brian T
• Assistant Examiner(s): TEJANI, ANKIT D
• Application Number:
  US14/276,652
• Publication Number:
  US 20140249602A1
• Time in Patent Office: 483 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: A61N 1/36053 adapted for vagal stimulation A61N1/36114 takes precedence
• CPC Class Codes: A61N 1/36064 Epilepsy
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/36135 using physiological parameters
• CPC Class Codes: A61N 1/36139 with automatic adjustment
• CPC Class Codes: A61N 1/36146 specified by the stimulation parameters
• CPC Class Codes: A61N 1/37235 Aspects of the external programmer
• CPC Class Codes: A61N 1/37247 User interfaces, e.g. input or presentation means
• CPC Class Codes: A61N 1/37264 Changing the program; Upgrading firmware
• CPC Class Codes: A61N 1/378 Electrical supply

Abstract

A system and method for estimating the longevity of an implantable medical device (IMD). In one embodiment of a method for estimating a life of a power source of an implantable medical device, a first life estimate of the power source is determined based on a first open-loop value corresponding to an open-loop parameter for open-loop therapy delivery, a first closed loop value corresponding to a closed-loop parameter for closed-loop therapy delivery, and prior usage data corresponding to prior therapy delivery. The first life estimate of the power source is displayed. The first life estimate displayed includes a first open-loop portion associated with open-loop therapy delivery and a first closed-loop portion associated with closed-loop therapy delivery.

Claims

1. A system for estimating a life of a power source of an implantable medical device (IMD), the system comprising:

a therapy logic configured to provide an open-loop stimulation therapy, an automatic closed-loop stimulation therapy, and a manually-initiated closed-loop stimulation therapy to a patient;

a detection logic coupled to the therapy logic, the detection logic configured to detect one or more events for triggering the automatic closed-loop stimulation therapy and the manually-initiated closed-loop stimulation therapy, and to record the one or more events; and

a control device coupled to the therapy logic and the detection logic, the control device configured to provide a first operable life estimate of the power source of the IMD, wherein the first operable life estimate identifies a first open-loop stimulation therapy portion of the first operable life estimate, a first automatic closed-loop stimulation therapy portion of the first operable life estimate, and a first manually-initiated closed-loop stimulation therapy portion, and where the first operable life estimate is based on an open-loop value corresponding to an open-loop parameter for the open-loop stimulation therapy, a closed-loop value corresponding to a closed-loop parameter for the automatic closed-loop stimulation therapy, a second closed-loop value corresponding to a manually-initiated closed-loop parameter for the manually-initiated closed-loop stimulation therapy, and a prior usage data corresponding to prior therapy delivery.

2. The system of claim 1, wherein the therapy logic is configured to enable a user to selectively enable and disable application of the automatic closed-loop stimulation therapy, the manually-initiated closed-loop stimulation therapy, and the open-loop stimulation therapy based in part on the first operable life estimate including the first open-loop therapy portion, the first automatic closed-loop stimulation therapy portion, and the first manually-initiated closed-loop stimulation therapy portion.

3. The system of claim 1, wherein the control device is configured to update the first operable life estimate based on changing a parameter value corresponding to at least one of the open-loop stimulation therapy, the automatic closed-loop stimulation therapy, and the manually-initiated closed-loop stimulation therapy.

4. The system of claim 1, wherein the control device is configured to retrieve control information from the IMD and to provide an estimation of an operable life of the power source based on the control information.

5. The system of claim 4, wherein the control information specifies a period and therapy level for the open-loop therapy, a first detection level and a first therapy level for the automatic closed-loop stimulation therapy, and a second detection level and a second therapy level for the manually-initiated closed-loop stimulation therapy.

6. The system of claim 1, wherein an estimation of an operable life of the power source represents an entire life of the power source.

7. The system of claim 1, wherein the control device is configured to store a plurality of operable life estimates, each estimate corresponding to a set of control information provided to a stimulation logic and the detection logic over a life of the power source, and to generate a display of the plurality of operable life estimates.

8. The system of claim 1, wherein the automatic closed-loop stimulation therapy and the manually-initiated closed-loop stimulation therapy to the patient are disabled, and wherein the first automatic closed-loop stimulation therapy portion is determined at least in part based on a count of automatic stimulation trigger events detected, and the first manually-initiated closed-loop stimulation therapy portion is determined at least in part on a count of manually-initiated stimulation requests detected.

9. A method, comprising:

determining a first operable life estimate of an implantable medical device (IMD), the first operable life estimate is based on a first operable life reduction attributable to a number of detected events operative to trigger an automatic closed-loop stimulation therapy, a second operable life reduction attributable to an open-loop stimulation therapy, and a third operable life reduction attributable to a manually-initiated closed-loop stimulation therapy;

identifying, for the first operable life estimate, a first open-loop stimulation therapy portion associated with the second operable life reduction, a first automatic closed-loop therapy portion associated with the first operable life reduction, and a first manually-initiated closed-loop stimulation therapy portion associated with the third operable life reduction.

10. The method of claim 9, further comprising:

displaying the first operable life estimate including the first open-loop stimulation therapy portion, the first automatic closed-loop stimulation therapy portion, and the first manually-initiated closed-loop stimulation therapy portion on an external device.

11. The method of claim 9, further comprising:

changing a value at the IMD, the value affecting any of an open-loop stimulation therapy level, an open-loop stimulation therapy rate, an automatic closed-loop detection level, and an automatic closed-loop therapy level, a manually-initiated closed-loop detection level, and a manually-initiated closed-loop therapy level;

determining a second operable life estimate of the IMD based on the changed value;

identifying, for the second operable life estimate, a second open-loop stimulation therapy portion, a second automatic closed-loop stimulation therapy portion, and a second manually-initiated closed-loop stimulation therapy portion based on the changed value; and

displaying the second operable life estimate including the second open-loop stimulation therapy portion, the second automatic closed-loop stimulation therapy portion, and the second manually-initiated closed-loop stimulation therapy portion on an external device.

12. The method of claim 11, further comprising:

displaying the first operable life estimate including the first open-loop stimulation therapy portion, the first automatic closed-loop stimulation therapy portion, and the first manually-initiated closed-loop stimulation therapy portion on the external device concurrently with the second operable life estimate including the second open-loop stimulation therapy portion, the second automatic closed-loop stimulation therapy portion, and the second manually-initiated closed-loop stimulation therapy portion.

13. The method of claim 12, wherein the first operable life estimate and the second operable life estimate are displayed prior to the IMD operating with the changed value.

14. The method of claim 9, further comprising:

storing a plurality of operable life estimates, each estimate corresponding to a different programming of the IMD over a life of the IMD; and

displaying the plurality of operable life estimates.

15. An apparatus for controlling an implantable medical device (IMD), the IMD having a power source, the apparatus comprising:

a processor operative to generate an operable life estimate for the power source based on a number of open-loop therapies delivered during a first time period, a number of closed-loop therapy detection events during the first time period, a charge consumption associated with each open-loop therapy delivery, and a charge consumption associated with each closed-loop therapy delivery, wherein the operable life estimate comprises an open-loop therapy portion corresponding to operable life of the IMD used for open-loop therapy delivery, an automatic closed-loop therapy portion corresponding to the operable life of the IMD used for automatic closed-loop therapy delivery, and a manually-initiated closed-loop therapy portion corresponding to an operable life of the IMD used for manually-initiated closed-loop therapy delivery; and

a display device coupled to the processor, the display device operative to display the operable life estimate generated by the processor including the open-loop therapy portion, the automatic closed-loop therapy portion, and the manually-initiated closed-loop therapy portion.

16. The apparatus of claim 15, wherein the processor is further operative to update the operable life estimate based on a change in one or more values affecting at least one of the open-loop therapy delivery, the automatic closed-loop therapy delivery, and the manually-initiated closed-loop therapy delivery.

17. The apparatus of claim 16, wherein the display device is operative to display an updated operable life estimate concurrently with the operable life estimate.

18. The apparatus of claim 17, wherein the updated operable life estimate and the operable life estimate are concurrently displayed prior to operation of the IMD with the changed one or more values.